Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over

Current obesity reports

Volumn 6, Issue 2, 2017, Pages 187-194

  Ryan, Donna H ^a   Yockey, Sarah Ryan ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dysglycemia; Dyslipidemia; Hypertension; Infertility; Non alcoholic fatty liver disease; Obesity; Obesity comorbidity; Obstructive sleep apnea; Polycystic ovarian syndrome; Type 2 diabetes; Weight loss; Weight loss and comorbidity improvement; Weight management

Indexed keywords

BIOLOGICAL MARKER; LIPID;

BLOOD; BLOOD PRESSURE; BODY WEIGHT LOSS; COMORBIDITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; HYPERTENSION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE; RISK FACTOR; SLEEP; SLEEP DISORDERED BREATHING; TREATMENT OUTCOME;

BIOMARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; LIPIDS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE; RISK FACTORS; SLEEP; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 85050578427     PISSN: None     EISSN: 21624968     Source Type: Journal    
DOI: 10.1007/s13679-017-0262-y     Document Type: Review

References (0)